Usak State Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00800527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Department of Ophtalmology, Usak State Hospital | Seref istek | Usak State Hospital

Active Ingredients

Drugs in Phase 4 Trials (3)

cyclosporine (sandimmune) (1 trial)

diclofenac (voltaren) (1 trial)

gabapentin (neurontin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chest Pain (Phase 4)

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Paresthesia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3